Lola Koktysh[email protected]MRIQuantitative imaging biomarkers show promise for NASHQuantitative imaging biomarkers are a promising approach for evaluating normal biological or pathogenic processes, as well as response to treatment and intervention. One near-term clinical application is the assessment of nonalcoholic steatohepatitis (NASH), according to Lola Koktysh of ScienceSoft.March 6, 2017Page 1 of 1Top StoriesNuclear MedicineEANM: Is ‘research fragmentation’ holding back nuclear medicine?Well-designed studies require collaboration among nuclear medicine, medical oncology, urology, radiation oncology, and clinical trial support.CTPCCT improves image quality when scanning patients with obesityWomens ImagingKaiser score outperforms MRI BI-RADS for inconclusive breast findingsMolecular ImagingFAPI-PET detects more HCC lesions than FDG-PETSponsor ContentFree Radiology Workflow Webinar